ELEVAR
Live / Applied — Fourth extension granted (statement of use) (as of 23 Feb 2026)
What this means for you
Not registered yet, but its 14 Aug 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98132276
- Mark type
- Design + words
- Filed
- 14 Aug 2023
- Published for opposition
- 19 Mar 2024
- Attorney of record
- Cynthia Johnson Walden
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations, namely, experimental and novel cancer therapeutics
Owner
- Elevar Therapeutics, Inc., Fort Lee, NJ, US
- Elevar Therapeutics, Inc., Salt Lake City, UT, US
Prosecution history
- 24 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 23 Feb 2026 — SOU EXTENSION 4 GRANTED
- 23 Feb 2026 — SOU EXTENSION 4 FILED
- 23 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 31 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Oct 2025 — SOU EXTENSION 3 GRANTED
- 31 Oct 2025 — SOU EXTENSION 3 FILED
- 31 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 13 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 May 2025 — SOU EXTENSION 2 GRANTED
- 12 May 2025 — SOU EXTENSION 2 FILED
- 12 May 2025 — SOU TEAS EXTENSION RECEIVED
- 21 Oct 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 15 Oct 2024 — SOU EXTENSION 1 GRANTED
- 15 Oct 2024 — SOU EXTENSION 1 FILED